A supplemental oxygen delivery system is described in which Aerosol is delivered into a housing 10, 20, which sits in the circuit from the supplemental oxygen supply and optional humidifier. The supplemental oxygen passes through this chamber 10, 20 in which the aerosol is located, and collects the aerosol transporting it to a patient via a nasal cannula 3 or a face mask 4. An aerosol generator 9 is mounted to the housing 10, 20 and delivers aerosol into an oxygen stream 13 flowing between an inlet 14 and an outlet 15 of the housing 10. The housing 10 also has a removable plug 16 in the base 17 thereof for draining any liquid that accumulates in the housing 10. There is no disruption of oxygen delivery to patients using nasal cannulas who currently have to use a separate face-mask when receiving nebulized medication.

A portable device for treatment of migraine having a desktop unit defining an airpath through a desiccant, a heat sink, an air mover and an air outlet, and a tubeset including a tube having one end for connecting to the desktop air outlet and a second end connected to a handheld unit, the handheld unit including a water compartment, and a nebulizer/transducer for introducing water droplets into the air stream. A nasal pillow is provided at the end of the handheld unit for placing against a user's nose.

The present invention relates to an apparatus and method for the generation of directed vapor from a liquid source. Vaporization takes place within a device capable of confining boiling to a geometrically small volume, and expelling it as heated vapor via capillary vaporization. The foregoing is accomplished through the use of a lightweight, compact and portable personal vaporization device that generates heated vapor by the flash boiling of small volumes of aqueous liquid in a safe and energy-efficient manner. Further, the production of vapor absent microbes in aqueous systems is accomplished through the combination of microporous componentry and flash vaporization. The apparatus and methods are directed toward personal humidification for comfort and therapeutic purposes in the case of aqueous liquids, but may also be used with other, non-aqueous liquids.

A surface acoustic wave (SAW) atomizer system for use in providing a nebulized medicament to a patient is described. The system may include a SAW atomization engine with an atomization region on a substrate that is separated from the interdigitated transducers (IDTs) on the substrate by a fluid barrier that seals off liquid fed into the atomization region from the adjacent IDTs and electrical contacts driving the IDTs.

Disclosed herein is a molecular imprinted protective face mask comprising a supportive structure, a surface material that receives and retains a molecular imprint and that is positioned to contact airborne molecules during use, a molecular imprint of a bioactive molecule wherein an imprinted cavity is at least one of a bioactive molecule with a molecular configuration that captures a specific airborne and/or microdroplet-borne molecule and a protein with a binding site that captures a specific molecule.

The present disclosure relates to methods for treating a respiratory system of a subject, as well as medicine delivery devices for delivering an aerosol medicine to a subject in need thereof. A benefit to the methods herein can be generating a respiratory pattern of a subject that can accurately measure inhalation and exhalation patterns, which can in turn provide a benefit of more efficient and timely delivery of an aerosol medicine to a subject in need thereof. Additional benefits to the methods and devices herein can be helping to improve treatment outcomes, as well as avoiding wastage of expensive medicines. Additional benefits to the medicine delivery devices disclosed herein can be non-invasive, low cost, lightweight, compact, versatile, and simple to use devices useful for a wide range of patients and healthcare settings. Another benefit of the medicine delivery devices can be providing a single-use device that can lower the risk of infection for patients and healthcare providers.

A ventilator system includes a gas flow chamber configured to receive ventilation gas circulating in a ventilation gas pathway of the ventilator and at least one UVC lamp. The UVC lamp is configured to radiate UVC spectrum light into the gas flow chamber to inactivate pathogens in the ventilation gas. A flow sensor is configured to measure a gas flow rate of the ventilation gas and a controller is configured to receive the gas flow rate, determine an intensity based on the gas flow rate, and control power to the UVC lamp based on the intensity.

There is provided a respirator for supplying clean air for a wearer. The respirator comprises a face assembly comprising an oronasal mask configured to seal against and cover a nose region and a mouth region of the wearer. The face assembly may be configured to be interchangeable on the respirator between a half-face assembly and a full-face assembly. The respirator comprises a securing headgear releasably securable with the face assembly, the securing headgear assembly configured to secure the respirator on a head of the wearer. The respirator comprises a facepiece assembly for supplying the wearer with air for inhaling and releasing air exhaled by the wear, the facepiece assembly releasably securable with the face assembly. One or more of the face assembly, the facepiece assembly, or the securing headgear are configured to be released from the respirator, sterilized, and releasably resecured with the respirator.

A breath-enhanced nebulizer adapted for use in administering an aerosolized pharmaceutical composition to a patient by inhalation wherein the patient is connected to a mechanical ventilator is disclosed. The nebulizer has a Venturi driven by a nebulizer air supply that draws a solution of a pharmaceutical composition into a shear zone where the solution is atomized. The Venturi effect is amplified by the internal configuration of the nebulizer to increase the rate of nebulization of drug. Optionally, breath-actuated nebulization is used, employing a pressure sensor interposed between the nebulizer and mechanical ventilator that controls the nebulizer air supply, such that nebulizer air and concomitant nebulization only occurs during the inhalation phase of a breathing cycle.

An inline adapter is provided including an elongated hollow body having an open first end configured to be connected to an inspiratory port of a patient ventilation assembly, an open second end opposite the first end, and a sidewall extending therebetween defining an airflow channel. The adapter also includes an inhaler port extending from the open second end of the adapter body configured to be connected to an inhaler, and an inspiratory branch having an open first end extending from an opening in the sidewall of the adapter body and an open second end configured to be connected to an inspiratory limb of the ventilation assembly. A longitudinal central axis of the inspiratory branch is angled relative to a longitudinal central axis of the adapter body.